News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
625,557 Results
Type
Article (25301)
Company Profile (546)
Press Release (599707)
Multimedia
Podcasts (182)
Webinars (20)
Section
Business (201570)
Career Advice (1571)
Deals (31633)
Drug Delivery (103)
Drug Development (74019)
Employer Resources (87)
FDA (13834)
Job Trends (11711)
News (300379)
Policy (25229)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (1509)
Academic (1)
Accelerated approval (48)
ADA (50)
Adcomms (26)
Allergies (173)
Alliances (40785)
ALS (211)
Alzheimer's disease (1571)
Antibody-drug conjugate (ADC) (536)
Approvals (14414)
Artificial intelligence (734)
ASCO (308)
Autoimmune disease (353)
Automation (62)
Bankruptcy (316)
Best Places to Work (9381)
BIO (65)
BIOSECURE Act (16)
Biosimilars (210)
Biotechnology (323)
Bladder cancer (209)
Brain cancer (74)
Breast cancer (805)
Cancer (6201)
Cardiovascular disease (508)
Career advice (1257)
Career pathing (34)
CAR-T (321)
CDC (31)
Celiac Disease (3)
Cell therapy (901)
Cervical cancer (53)
Clinical research (66746)
Collaboration (2129)
Commercialization (1)
Company closure (6)
Compensation (1572)
Complete response letters (90)
COVID-19 (1769)
CRISPR (109)
C-suite (1145)
Cystic fibrosis (141)
Data (8604)
Decentralized trials (2)
Denatured (61)
Depression (181)
Dermatology (104)
Diabetes (661)
Diagnostics (5807)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (18)
Drug discovery (379)
Drug pricing (126)
Drug shortages (21)
Duchenne muscular dystrophy (304)
Earnings (87915)
Editorial (49)
Employer branding (11)
Employer resources (78)
Events (108706)
Executive appointments (1079)
FDA (17766)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1728)
Gene editing (239)
Generative AI (72)
Gene therapy (716)
GLP-1 (966)
Government (2673)
Grass and pollen (6)
Guidances (411)
Healthcare (14033)
Hematology (176)
HIV (93)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (318)
Immuno-oncology (112)
Indications (221)
Infectious disease (2134)
Inflammatory bowel disease (209)
Inflation Reduction Act (13)
Influenza (143)
Intellectual property (308)
Interviews (282)
IPO (15352)
IRA (41)
Job creations (2769)
Job search strategy (1073)
JPM (44)
Kidney cancer (24)
Labor market (95)
Layoffs (378)
Leadership (35)
Legal (6327)
Liver cancer (93)
Longevity (31)
Lung cancer (823)
Lymphoma (460)
Machine learning (58)
Management (27)
Manufacturing (1007)
Marketing (7)
MASH (218)
Medical affairs (1)
Medical device (11515)
Medtech (11694)
Mergers & acquisitions (17523)
Metabolic disorders (1619)
mRNA (161)
Multiple sclerosis (197)
NASH (20)
Neurodegenerative disease (492)
Neuropsychiatric disorders (112)
Neuroscience (3166)
Neurotech (2)
NextGen: Class of 2026 (4776)
Non-profit (2787)
Now hiring (43)
Obesity (728)
Opinion (220)
Ovarian cancer (230)
Pain (266)
Pancreatic cancer (349)
Parkinson's disease (365)
Partnered (32)
Patents (605)
Patient recruitment (751)
Peanut (59)
People (48456)
Pharmaceutical (78)
Pharmacy benefit managers (24)
Phase 1 (20213)
Phase 2 (29085)
Phase 3 (22528)
Pipeline (9894)
Policy (230)
Postmarket research (2276)
Preclinical (8362)
Press Release (46)
Prostate cancer (329)
Psychedelics (64)
Radiopharmaceuticals (313)
Rare diseases (1151)
Real estate (4147)
Recruiting (36)
Regulatory (21568)
Reports (47)
Research institute (1490)
Resumes & cover letters (287)
Rett syndrome (46)
RNA editing (27)
RSV (80)
Schizophrenia (183)
Series A (285)
Series B (204)
Service/supplier (14)
Sickle cell disease (120)
Special edition (30)
Spinal muscular atrophy (168)
Sponsored (39)
Startups (2779)
State (1)
Stomach cancer (17)
Supply chain (118)
Tariffs (57)
The Weekly (120)
Vaccines (909)
Venture capital (106)
Weight loss (466)
Women's health (136)
Worklife (12)
Date
Today (95)
Last 7 days (441)
Last 30 days (1910)
Last 365 days (29624)
2026 (16740)
2025 (29433)
2024 (32594)
2023 (34678)
2022 (43942)
2021 (47134)
2020 (43749)
2019 (34140)
2018 (25840)
2017 (26538)
2016 (25081)
2015 (31339)
2014 (27055)
2013 (22607)
2012 (24570)
2011 (24840)
2010 (23873)
Location
Africa (578)
Alabama (96)
Alaska (5)
Arizona (341)
Arkansas (14)
Asia (32912)
Australia (5355)
California (14093)
Canada (3828)
China (1423)
Colorado (584)
Connecticut (606)
Delaware (416)
Europe (65664)
Florida (2063)
Georgia (435)
Hawaii (4)
Idaho (53)
Illinois (1166)
India (83)
Indiana (604)
Iowa (24)
Japan (615)
Kansas (130)
Kentucky (46)
Louisiana (58)
Maine (69)
Maryland (1611)
Massachusetts (10150)
Michigan (364)
Minnesota (729)
Mississippi (7)
Missouri (135)
Montana (34)
Nebraska (19)
Nevada (153)
New Hampshire (91)
New Jersey (3679)
New Mexico (29)
New York (3670)
North Carolina (1707)
North Dakota (8)
Northern California (7081)
Ohio (394)
Oklahoma (24)
Oregon (30)
Pennsylvania (2704)
Puerto Rico (30)
Rhode Island (44)
South America (838)
South Carolina (87)
South Dakota (1)
Southern California (5598)
Tennessee (190)
Texas (2240)
United States (49099)
Utah (414)
Vermont (1)
Virginia (313)
Washington D.C. (69)
Washington State (1134)
West Virginia (4)
Wisconsin (148)
Wyoming (1)
625,557 Results for "h3 biomedicine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at ASCO 2026
June 3, 2026
·
4 min read
Press Releases
Palleon Pharmaceuticals Presents First-in-Class B7-H3 Targeted Sialidase at the 2026 AACR Annual Meeting
April 20, 2026
·
3 min read
Press Releases
Artios Announces Clinical Trial Collaboration with GSK to Evaluate Alnodesertib in Combination with Risvutatug Rezetecan, a B7-H3-Targeted ADC in Gastrointestinal Tumors
May 12, 2026
·
3 min read
Press Releases
Palleon Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of E-688/HLX316, a First-in-Class B7-H3-Targeted Sialidase for Advanced Solid Tumors
May 27, 2026
·
3 min read
Press Releases
Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety
April 21, 2026
·
2 min read
Press Releases
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
May 4, 2026
·
7 min read
Press Releases
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
May 22, 2026
·
12 min read
Press Releases
Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China
January 23, 2026
·
2 min read
Press Releases
Microbix Launches New Products to Support H3N2 Flu Testing
December 10, 2025
·
5 min read
Press Releases
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential First-In-Class B7H3/PTK7 Bispecific TOP1 ADC
February 25, 2026
·
5 min read
1 of 62,556
Next
